Origin of aldosterone in the rat heart.

Aldosterone has been demonstrated in the perfusate of the ex situ rat heart and heart homogenates; however, the origin of aldosterone in the heart is controversial, with some reporting a primary role for extraadrenal synthesis within the heart, and others finding that all of the aldosterone in the heart is sequestered from the circulation. In an attempt to resolve this controversy, we measured the aldosterone and corticosterone contents of plasma and hearts of rats on a normal salt (NS), low salt (LS), or high salt (HS) diet, adrenalectomized (ADX+HS), and ADX with aldosterone replacement or deoxycorticosterone excess (ADX+HS+DOC) before tissue harvest. The sodium content of the diet had no significant effect on corticosterone levels in the plasma or heart. LS significantly increased, whereas HS decreased the aldosterone content of plasma and heart compared with NS. Corticosterone levels in both plasma and heart and aldosterone levels in plasma of ADX-HS rats were undetectable in most individuals and were extremely low in very few. Although plasma aldosterone was undetectable, aldosterone was measurable in 30% of the hearts of 84 ADX+HS rats, albeit at low levels. The aldosterone and corticosterone contents of the hearts of ADX+HS+DOC were similar to those of ADX+HS, indicating that aldosterone synthase and 11beta-hydroxylase, not substrate, are the limiting factors for extraadrenal synthesis of corticosteroids in the heart. In conclusion, we found that the level of aldosterone content in the healthy rat heart in vivo is significantly lower than that reported elsewhere and reflects plasma levels in intact rats.

[1]  B. Pitt,et al.  Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .

[2]  Takashi Yamamoto,et al.  Transcardiac Gradient of Aldosterone Before and After Spironolactone in Patients with Congestive Heart Failure , 2003, Journal of cardiovascular pharmacology.

[3]  K. Nakao,et al.  Expression of aldosterone synthase gene in failing human heart: quantitative analysis using modified real-time polymerase chain reaction. , 2002, The Journal of clinical endocrinology and metabolism.

[4]  T. Masuda,et al.  Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart. , 2002, Clinical science.

[5]  A. Capponi Regulation of cholesterol supply for mineralocorticoid biosynthesis , 2002, Trends in Endocrinology & Metabolism.

[6]  M. Young,et al.  Cardiac steroidogenesis in the normal and failing heart. , 2001, The Journal of clinical endocrinology and metabolism.

[7]  I. Miyamori,et al.  Effects of high sodium intake on cardiovascular aldosterone synthesis in stroke-prone spontaneously hypertensive rats , 2001, Journal of hypertension.

[8]  K. Kugiyama,et al.  Aldosterone Production Is Activated in Failing Ventricle in Humans , 2001, Circulation.

[9]  H. Rennke,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy* , 2022 .

[10]  I. Miyamori,et al.  Cardiac Aldosterone Production in Genetically Hypertensive Rats , 2000, Hypertension.

[11]  M. Kinoshita,et al.  Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. , 2000, Journal of the American College of Cardiology.

[12]  M. Young,et al.  Aldosterone and the Heart , 2000, Trends in Endocrinology & Metabolism.

[13]  E. Blasi,et al.  Tissue-specific corticosteroidogenesis in the rat , 2000, Molecular and Cellular Endocrinology.

[14]  P. White,et al.  Steroidogenic enzyme gene expression in the human heart. , 2000, The Journal of clinical endocrinology and metabolism.

[15]  I. Miyamori,et al.  Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy. , 2000, Endocrinology.

[16]  B. Pitt,et al.  The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.

[17]  A. Carayon,et al.  , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of , 1999 .

[18]  Y. Takeda,et al.  Aldosterone Overproduction and CYP11B2 mRNA Overexpression in Vessels of Spontaneously Hypertensive Rats , 1998, Hormone Research in Paediatrics.

[19]  C. Delcayre,et al.  Myocardial Production of Aldosterone and Corticosterone in the Rat , 1998, The Journal of Biological Chemistry.

[20]  H. Morita,et al.  Aldosterone biosynthesis in the rat brain. , 1997, Endocrinology.

[21]  H. Hense,et al.  Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass. , 1997, Heart.

[22]  Hiroshi Yamamoto,et al.  The expression of steroidogenic enzyme genes in human vascular cells , 1996, Biochemistry and molecular biology international.

[23]  I. Miyamori,et al.  Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocorticotropin. , 1996, The Journal of clinical endocrinology and metabolism.

[24]  C. Gomez-Sanchez,et al.  Stable expression of rat cytochrome P450 11β-Hydroxylase (CYP11B1) and aldosterone synthase (CYP11B2) in MA-10 cells , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[25]  Hiroshi Yamamoto,et al.  Aldosterone biosynthesis and action in vascular cells , 1995, Steroids.

[26]  G. Vinson,et al.  Effects of chronic corticotrophin treatment on aldosterone metabolism in the rat. , 1993, The Journal of endocrinology.

[27]  C. Gomez-Sanchez,et al.  Biotin-hydrazide derivatives for the development of steroid enzyme-linked immunoassays , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[28]  M. Okamoto,et al.  Functional expression of the cDNAs encoding rat 11β-hydroxylase [cytochrome P450(11β)] and aldosterone synthase [cytochrome P450(11β, aldo)] , 1991 .

[29]  M. Boscaro,et al.  An ultrastructural stereological study of accessory adrenocortical glands in bilaterally adrenalectomised rats. , 1989, Journal of anatomy.

[30]  H. Schulte,et al.  PHARMACOKINETICS OF ALDOSTERONE IN PATIENTS WITH ADDISON'S DISEASE: EFFECT OF RIFAMPICIN TREATMENT ON GLUCOCORTICOID AND MINERALOCORTICOID METABOLISM , 1987, Clinical endocrinology.

[31]  M. Waterman,et al.  Neurosteroids: cytochrome P-450scc in rat brain. , 1987, Science.

[32]  C. Gomez-Sanchez,et al.  The production of monoclonal antibodies against aldosterone , 1987, Steroids.

[33]  C. Gomez-Sanchez,et al.  Urinary free 19-nor-deoxycorticosterone and deoxycorticosterone in human hypertension. , 1985, The Journal of clinical endocrinology and metabolism.

[34]  K. Catt,et al.  Loci of action of regulators of aldosterone biosynthesis in isolated glomerulosa cells. , 1979, Endocrinology.

[35]  Prof. Dr. med. Jürg Müller,et al.  Regulation of Aldosterone Biosynthesis , 1971, Monographs on Endocrinology.

[36]  B. Pitt,et al.  EPLERENONE POST-ACUTE MYOCARDIAL INFARCTION HEART FAILURE EFFICACY AND SURVIVAL STUDY INVESTIGATORS. EPLERENONE, A SELECTIVE ALDOSTERONE BLOCKER, IN PATIENTS WITH LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 2003 .

[37]  D. Duprez,et al.  Aldosterone and vascular damage , 2000, Current hypertension reports.

[38]  I. Miyamori,et al.  Vascular aldosterone in genetically hypertensive rats. , 1997, Hypertension.

[39]  I. Miyamori,et al.  3. Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells , 1994, The Journal of biological chemistry.

[40]  K. Weber,et al.  Myocardial fibrosis: role of angiotensin II and aldosterone. , 1993, Basic research in cardiology.